
    
      After getting informed consent from guardian,148 patients of acute moderate ro severe asthma
      with pediatric asthma score 8-15 will be randomly classified into 2 groups and one group will
      receive nebulization with magnesium sulphate and other will receive intravenous magnesium
      sulphate and effectiveness will be compared by 4 point reduction in PAS from baseline in
      either groups after 6 hours.
    
  